Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
1.110
-0.030 (-2.63%)
At close: Aug 13, 2025, 4:00 PM
1.170
+0.060 (5.41%)
Pre-market: Aug 14, 2025, 9:10 AM EDT

Autonomix Medical Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22
Selling, General & Admin
6.596.565.251.2513.59
Research & Development
5.364.732.230.750
Other Operating Expenses
0.30.3---
Operating Expenses
12.2611.597.471.9913.59
Operating Income
-12.26-11.59-7.47-1.99-13.59
Interest Expense
-0.14-0.18-0.08--0.22
Interest & Investment Income
0.340.350.13--
Other Non Operating Income (Expenses)
---8-0.31
EBT Excluding Unusual Items
-12.05-11.41-15.43-1.99-13.5
Other Unusual Items
----0.17
Pretax Income
-12.05-11.41-15.43-1.99-13.33
Net Income
-12.05-11.41-15.43-1.99-13.33
Preferred Dividends & Other Adjustments
-----0.49
Net Income to Common
-12.05-11.41-15.43-1.99-12.84
Shares Outstanding (Basic)
22110
Shares Outstanding (Diluted)
22110
Shares Change (YoY)
88.56%69.73%73.12%480.20%-
EPS (Basic)
-5.39-6.46-14.82-3.31-123.94
EPS (Diluted)
-5.39-6.46-14.82-3.31-123.94
Free Cash Flow
-9.02-8.27-6.67-1.85-0.39
Free Cash Flow Per Share
-4.03-4.68-6.41-3.08-3.74
EBITDA
-12.11-11.41-7.39--
D&A For EBITDA
0.140.180.08--
EBIT
-12.26-11.59-7.47-1.99-13.59
Advertising Expenses
--1.8--
Updated May 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q